Pune, India, Feb. 11, 2021 (GLOBE NEWSWIRE) -- According to the report, DNA Sequencing market size is projected to reach remarkable value by 2026. The rising advancements in DNA sequencing technologies is expected to enable growth of the global DNA sequencing market. The rising prevalence of various cancers and genetic diseases is expected to contribute to growth of the market.
The collaboration of Nebula Genomics with Merck KGaA is predicted to aid growth of the DNA sequencing market. For instance, Nebula Genomics announced its collaboration Merck KGaA with the goal to enhance drug discovery for lung cancer patients and offering a free high-coverage germ line and tumor whole-genome sequencing.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dna-sequencing-market-101527
Increasing Partnerships And Collaborations Will Encourage Growth
The launch of Morphoseq Long Read DNA Sequencing Technology is predicted to contribute to the DNA sequencing market growth. For instance, Longas Technologies launched Morphoseq Long Read DNA Sequencing Technology which is designed to improve the NGS platforms by increasing effective read lengths, providing benefits of high accuracy and cost efficiency sequencing.
Furthermore, increasing applications of DNA sequencing in imaging, nanotechnology, bioinformatics, and development of effective gene therapy, for the treatment of various types of diseases are likely to drive the DNA sequencing market growth during the forecast period. In addition, growing applications of DNA sequencing in pharmacogenomics will fuel demand for the development of personalized medicines. This factor will boost the market growth during the forecast period.
However, the lack of skilled professionals and low awareness about the emerging technologies in DNA sequencing in low-middle income countries is likely to hinder the growth of the market during the forecast period.
The rising adoption of new technology in DNA sequencing and surge inpatient population will further stimulate growth in the region. In the Middle East & Africa, growing unmet needs for the cost-effective diagnosis of various diseases is likely to accelerate the growth of the market in the region.
Click here to get the short-term and long-term impacts of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/dna-sequencing-market-101527
Presence Of Key Players Will Enable Growth North America
North America is expected to dominate the market during the forecast period owing to the presence of key players in the region. The rising prevalence of various genetic disorders and growing investments by key players for the development of technological advanced DNA sequencing technology will further boost growth in North America. In Europe, rising awareness about the growing application of DNA sequencing in developing effective gene therapy is likely to drive the market during the forecast period. In the Asia Pacific and Latin America, the market is expected to grow at a significant rate owing to the growing prevalence of various chronic disorders & cancers.
Quick Buy - DNA Sequencing Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101527
Several companies present in the global market for DNA Sequencing are striving to compete with their rivals by either engaging in mergers & acquisitions, or by conducting novel clinical research studies.
- Abbott, Danaher
- F. Hoffmann-La Roche Ltd
- Illumina, Inc.
- LI-COR, Inc.
- Pacific Biosciences of California, Inc.
- Siemens
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/queries/dna-sequencing-market-101527
Global DNA Sequencing Market Segmentation:
By Type:
- Instruments
- Reagents & Consumables
- Workflow Products
- Services
By Technology:
- Next Generation DNA Sequencing
- Sanger Sequencing
By Application:
- Research & Clinical Trials
- Disease Diagnosis
- Forensics
- Others
By End-User:
- Biotechnology & Pharmaceutical Industries
- Diagnostic Centers
- Hospitals & Clinics
- Academic & Research Institutes
- Others
By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/dna-sequencing-market-101527
Have a Look at Related Reports:
Neonatal Intensive Care Market Size, Share & Industry Analysis, By Product (Neonatal Incubators, Neonatal Phototherapy Equipment, Neonatal Ventilators, Neonatal Monitors, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2020-2027
Lymphoma Treatment Market Size, Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (Non-Hodgkin Lymphoma, and Hodgkin Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2019-2026
Diabetic Neuropathy Market Size, Share & Industry Analysis, By Disease Type (Peripheral, Autonomic, Proximal, and Focal), By Drug Class (Anti-Depressants, Anti-Seizures, Opioid, Non-Steroidal Anti-Inflammatory, and others), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Online Pharmacies), and Regional Forecast, 2019-2026
Teleradiology Market Size, Share & Industry Analysis, By Imaging Technique (X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, Nuclear Medicine, and Others), By Component (Services & Software, and Product), By End User (Hospitals & Clinics, Diagnostic Centers and Others), and Regional Forecast, 2019-2026
Transcatheter Heart Valve Replacement (THVR) Market Size, Share & Industry Analysis, By Product Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), and Transcatheter Pulmonary Valve Replacement (TPVR)), By End User (Hospitals, and Specialty Clinics& Others), and Regional Forecast, 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs